BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34365980)

  • 1. Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.
    Matzen E; Bartels LE; Løgstrup B; Horskær S; Stilling C; Donskov F
    Cardiooncology; 2021 Aug; 7(1):27. PubMed ID: 34365980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.
    Nakagomi Y; Tajiri K; Shimada S; Li S; Inoue K; Murakata Y; Murata M; Sakai S; Sato K; Ieda M
    Front Pharmacol; 2022; 13():884776. PubMed ID: 35645839
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
    Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil.
    Jespersen MS; Fanø S; Stenør C; Møller AK
    Eur Heart J Case Rep; 2021 Nov; 5(11):ytab342. PubMed ID: 34870082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid-resistant immune-related adverse events: a systematic review.
    Daetwyler E; Wallrabenstein T; König D; Cappelli LC; Naidoo J; Zippelius A; Läubli H
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38233099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series.
    Zhang RS; Padegimas A; Murphy KM; Evans PT; Peters CJ; Domenico CM; Vidula MK; Mather PJ; Cevasco M; Cohen RB; Carver JR; O'Quinn RP
    Cardiooncology; 2021 Mar; 7(1):13. PubMed ID: 33785062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.
    Deharo F; Carvelli J; Cautela J; Garcia M; Sarles C; Maues de Paula A; Bourenne J; Gainnier M; Bichon A
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.
    Liu Q; Yu Y; Lin J; Wang Y; Ai L; Li Q; Wu W; Jin H; Li S; Liu M; Yu S; Liu T
    Eur J Cancer; 2021 Nov; 157():10-20. PubMed ID: 34464781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 inhibitors-associated myocarditis in non-small cell lung cancer patients.
    He Y; Chen W; Cai J; Luo C; Zhou C; Wei L
    J Thorac Dis; 2023 Sep; 15(9):4606-4619. PubMed ID: 37868865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
    Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
    J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment of Steroid-Refractory Checkpoint Inhibitor Myocarditis with Globulin Derived-Therapy: A Case Report and Literature Review.
    Barry T; Gallen R; Freeman C; Agasthi P; Pedrotty D; Yang M; Jokerst CE; Mookadam F; Hardaway BW; LeMond L; Arsanjani R; Larsen C
    Am J Med Sci; 2021 Oct; 362(4):424-432. PubMed ID: 33974854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitor-associated myocarditis: a systematic analysis of case reports.
    Wang C; Zhao G; Zhang Z; Yang L; Liu S; Li G; Wang H; Huang J; Wang S; Li N
    Front Immunol; 2023; 14():1275254. PubMed ID: 37876928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.
    Peleg Hasson S; Salwen B; Sivan A; Shamai S; Geva R; Merimsky O; Raphael A; Shmilovich H; Moshkovits Y; Kapusta L; Rozenbaum Z; Wolf I; Laufer-Perl M
    Clin Res Cardiol; 2021 Jan; 110(1):50-60. PubMed ID: 32296970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoint Inhibitor-Associated Myocarditis: A Literature Review.
    Gul R; Shehryar M; Mahboob A; Kareem HK; Inayat A; Safi D; Kamran A
    Cureus; 2024 Jan; 16(1):e52952. PubMed ID: 38406102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibitor myocarditis in thymic epithelial tumors: a case report and literature review.
    Feng Y; Zheng P; Zhang W; Yang S; You Y; Chen Y; Ye Y
    Transl Cancer Res; 2024 Feb; 13(2):1208-1218. PubMed ID: 38482422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases.
    Zotova L
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression.
    Mohammad KO; Fanous H; Vakamudi S; Liu Y
    Cardiooncology; 2023 Mar; 9(1):15. PubMed ID: 36941689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept.
    Nguyen LS; Bretagne M; Arrondeau J; Zahr N; Ederhy S; Abbar B; Pinna B; Allenbach Y; Mira JP; Moslehi J; Rosenzwajg M; Salem JE
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.